AVF 30 Years: Past, Present and Looking to the Future
The site of this year’s event will be the J.W. Marriott Tucson Starr Pass Resort & Spa in Tucson. Detailed information and registration is available at veinforum.org.
AVF President Marc A. Passman, MD, said that while many of the events are traditional favorites of returning members, there will be special activities that will honor the 30th anniversary of the AVF.
The David S. Sumner Venous Summit Wednesday, Feb. 21, will highlight the 30th anniversary with the topic “AVF 30 Years: Past, Present and Looking to the Future” as a framework for discussion of critical scientific events. In addition, the President’s Session on the final day will include a 30th Anniversary panel discussion.
While looking back and projecting forward is important, most of the activities are the medical and scientific events that have become the familiar foundations of the annual meetings.
“What highlights this 30th Anniversary Annual Meeting is the unsurpassed scientific program that brings people back year after year,” Dr. Passman said. “They come to learn from the internationally recognized authorities on all aspects of venous and lymphatic disease, diagnosis, pathophysiology and treatment.
“Those events that encourage current thinking in effective clinical management of venous and lymphatic disease, and provide valuable insight into the future directions from critical analysis of investigative findings are still the mainstay of the program.”
He said the objectives of these comprehensive meetings are to provide attendees with knowledge of current thinking in effective clinical management of venous and lymphatic disease and insight into the future directions from critical analysis of investigative findings.
Hundreds of representatives from leading vascular healthcare companies that share the vision of improving patient outcomes and quality of care for individuals with venous disease will exhibit the latest products and services.
The 30th AVF Annual Meeting is designed to enhance networking with about 50 industry partners and more than 600 expected attendees. The exhibit hall is open every day during the Annual Meeting.
In addition, there will be breakfasts, receptions, coffee breaks, lunch and dinner opportunities and hospitality events that will encourage casual sharing of information and ideas.
There will be six scientific sessions for oral presentations arranged by topic, including deep venous and chronic venous occlusion; superficial venous; venous thromboembolism, imaging and diagnostics, and additional scientific sessions.
In addition, there will be a half dozen panel discussions, the Strandness Memorial Lecture, International Symposium, Specialty Symposia, The Villavicencio Symposium, Live Imaging Superficial Venous Symposia, and Symposia on IVC Filter Complications and a debate on whether to take them out or leave them in.
The Day of Innovation and Science will mark its third year at the 30th Annual Meeting on Tuesday, Feb. 20. Ever since its inception, the Day of Innovation and Science has been an informative, all-inclusive (non-CME) forum designed to identify current research priorities in the area of venous and lymphatic diseases.
This year, the day-long forum will explore “Basic Science and Bioengineer” from an educational viewpoint in the morning and from an industry position in the afternoon.
The AVF Day of Innovation and Science was originally designed to bring together all major stakeholders in the field of venous and lymphatic disease including representatives of industry; government agencies such as NIH, FDA and CMS; private payers; basic scientists; clinical researchers; and practitioners.
Through participation in the Day of Innovation and Science, the representatives of these different sectors will address the state of the field, discuss next steps for closing knowledge gaps in the two highlighted areas, discover the role data can play in influencing, positive changes in coverage, and ultimately, identify what is needed to improve medical treatment of patients with venous and lymphatic disease.
A new feature this year will be the Early Career Venous Session covering discussions of interest to those beginning their practice. Coding and billing tips; how to approach pelvic disorders; how to set up a successful outpatient vein practice; how to balance venous and arterial work; and how to collaborate with a wound care center.
On Wednesday, Feb. 21, the David S. Sumner Venous Summit will frame several discussions within the last 30 years by the past, the present and the future. Those topics will include classification of chronic venous disease, treatment of Iliofemoral DVT, venous leg ulcers, and appropriateness in venous care.
Afternoon features include Scientific Session 1: Deep Venous and Chronic Venous Occlusion, and for a variation in thinking, the best paper from the Society of Venous Medicine will present Thrombophilia Topics; and the best paper from the American College of Phlebology on the subject of Management of Middle-size Veins be presented. They will be followed by the International Symposium, which will include Spanish translation and the Villavicencio Symposium, which will highlight important randomized studies in venous and lymphatic disease.
Thursday, Feb. 22, will feature Scientific Session 2 (Superficial Venous) in the morning and Scientific Session 3 (Venous Thromboembolism). The D. Eugene Strandness Memorial Lecture will be given by Peter Lawrence, MD.
Friday, Feb. 23, will include Scientific Session 4 on Imaging and Diagnostics. The 30th Anniversary Panel is a part of the President’s Session Friday afternoon and will honor the AVF founding members. The Presidential session will highlight many of the accomplishment of the AVF over the past year, culminating in the Presidential Address.
The afternoon includes the annual member business meeting, Live Imaging Superficial Venous Symposia and symposia on IVC Filter Complications and other Tough Problems.
Several activities are planned to raise money to support pioneering research, medical education and awareness of venous and lymphatic health during the Annual Meeting. These include the Venous Open Golf Tournament, and the silent auction.
The AVF will host the 2018 Venous Open Golf Tournament at 1 p.m. Thursday, Feb. 22, at the Starr Pass Golf Club, on property at the JW Marriott Tuscon Starr Pass Resort & Spa.
Building off the past 30 years, the AVF 2018 Annual Meeting will continue to highlight its dedication to improving the care of patients with venous and lymphatic disease through quality educational programs and innovative research, delivered in the beautiful Tuscon setting. VTN